Cambridge, Massachusetts-based Aura Biosciences, a biotechnology company, has raised $8 million in funding. The investors included Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and Termeer. In addition to the funding, Henri Termeer, former CEO of Genzyme, has been added to Aura Biosciences’ board of directors.

Source: Press Release